Drug Profile


Alternative Names: SQ 27239

Latest Information Update: 12 Sep 1997

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bristol-Myers Squibb
  • Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antirheumatics; Corticosteroids
  • Mechanism of Action Arachidonic acid inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Allergic rhinitis; Asthma; Skin disorders

Most Recent Events

  • 12 Sep 1997 Discontinued-Clinical for Skin disorders in USA (Topical)
  • 12 Sep 1997 Discontinued-Unspecified for Skin disorders in Italy (Topical)
  • 12 Sep 1997 Discontinued-Unspecified for Skin disorders in Japan (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top